Insurance Coverage Desk

Mothers depression linked to child disorders

By 13/11/2026 2 min read 16 views
Mothers depression linked to child disorders - mothers depression
The investigation, conducted by Saraid McIlvride from the University of Glasgow, examined health data for more than 167,000 Welsh children born between 2009 and 2016.

Research in PLOS Medicine reveals that offspring of mothers dealing with depression face raised chances of developing specific neurodevelopmental conditions, even if their mothers did not take antidepressants during pregnancy. The investigation, conducted by Saraid McIlvride from the University of Glasgow, examined health data for more than 167,000 Welsh children born between 2009 and 2016.

The Glasgow-based researchers cross-referenced medical and educational records to identify any connections between maternal depression or antidepressant prescriptions and later special educational needs in children—including autism spectrum disorder, ADHD, or related challenges. Their findings indicated that children whose mothers took antidepressants showed higher rates of neurodevelopmental issues compared to those whose mothers had depression but did not use medication.

The study acknowledges that women with more severe depression are typically prescribed antidepressants, which could skew the results. When comparing untreated depression, treated depression, and antidepressant use without depression, the data showed that prenatal antidepressant exposure added 6.3 cases per 100 children in non-depressed mothers and 2.9 cases per 100 children in depressed mothers.

McIlvride’s team emphasizes that children of depressed mothers are at greater risk for neurodevelopmental disorders, whether or not antidepressants were involved, though medication may introduce extra risk. They stress that any treatment-related concerns must be weighed against the dangers of untreated depression, which is linked to higher postnatal depression risks for mothers.

The researchers urge that their findings should not lead women to abruptly discontinue antidepressants, as untreated depression poses risks to both mother and baby. Instead, they recommend consulting healthcare providers to determine the best approach. The study also suggests that prenatal antidepressant exposure could signal the need for additional school support for affected children.

McIlvride and her team believe that linking mothers’ and babies’ routinely collected data and being able to follow their health and development over time is a valuable resource that can support research into maternal mental health, an area that urgently needs more attention. Further studies are needed to empower women with the knowledge they need to make informed decisions, together with their doctor or midwife, about their own health as well as their baby’s.

McIlvride and her team hope that their research will contribute to a better understanding of the relationship between prenatal exposure to maternal depression and antidepressants and neurodevelopmental outcomes. By examining the effects of antidepressant use during pregnancy on child development, the study aims to provide valuable insights for mothers, healthcare providers, and policymakers. The study’s findings will help inform decisions about treatment and support for mothers with depression and their children.

Leave a Comment

Your email address will not be published. Required fields are marked *